← All medicines
Ranolazine Accord 500 mg prolonged-release tablet
Licence PA2315/259/002 · Not marketed
- Licence holder
- Accord Healthcare Ireland Ltd. (all products →)
- Active substance
- Ranolazine
- Dosage form
- Prolonged-release tablet
- Route of administration
- Oral use
- ATC code
- C01EB18
- First authorised
- 19/07/2024
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.